Cargando…

Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization

Radiomics and genomics represent two of the most promising fields of cancer research, designed to improve the risk stratification and disease management of patients with prostate cancer (PCa). Radiomics involves a conversion of imaging derivate quantitative features using manual or automated algorit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferro, Matteo, de Cobelli, Ottavio, Vartolomei, Mihai Dorin, Lucarelli, Giuseppe, Crocetto, Felice, Barone, Biagio, Sciarra, Alessandro, Del Giudice, Francesco, Muto, Matteo, Maggi, Martina, Carrieri, Giuseppe, Busetto, Gian Maria, Falagario, Ugo, Terracciano, Daniela, Cormio, Luigi, Musi, Gennaro, Tataru, Octavian Sabin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465891/ https://www.ncbi.nlm.nih.gov/pubmed/34576134 http://dx.doi.org/10.3390/ijms22189971

Ejemplares similares

Radiomics in prostate cancer: an up-to-date review
por: Ferro, Matteo, et al.
Publicado: (2022)

Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
por: Ferro, Matteo, et al.
Publicado: (2023)

Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement
por: Ferro, Matteo, et al.
Publicado: (2023)

Beyond PSA: The Role of Prostate Health Index (phi)
por: Ferro, Matteo, et al.
Publicado: (2020)

Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review
por: Ferro, Matteo, et al.
Publicado: (2023)

Molecular Imaging Diagnosis of Renal Cancer Using (99m)Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
por: Tataru, Octavian Sabin, et al.
Publicado: (2023)

Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy
por: Ferro, Matteo, et al.
Publicado: (2022)

Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies
por: Ferro, Matteo, et al.
Publicado: (2020)

Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center
por: Annese, Pasquale, et al.
Publicado: (2021)

SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study
por: Maggi, Martina, et al.
Publicado: (2021)

Quality of Life and Psychological Distress among Patients with Small Renal Masses
por: Vartolomei, Liliana, et al.
Publicado: (2022)

Outcomes of robot-assisted simple enucleation of renal masses: A single European center experience
por: Matei, Deliu Victor, et al.
Publicado: (2017)

Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity
por: Busetto, Gian Maria, et al.
Publicado: (2020)

Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors
por: Balan, Daniel, et al.
Publicado: (2018)

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk?
por: Aveta, Achille, et al.
Publicado: (2022)

The Efficacy of Flogofilm(®) in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
por: Barone, Biagio, et al.
Publicado: (2023)

PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
por: Bruno, Salvatore M., et al.
Publicado: (2021)

Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis
por: Ferro, Matteo, et al.
Publicado: (2021)

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
por: Crocetto, Felice, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data
por: Maggi, Martina, et al.
Publicado: (2021)

Does Exist a Differential Impact of Degarelix Versus LHRH Agonists on Cardiovascular Safety? Evidences From Randomized and Real-World Studies
por: Sciarra, Alessandro, et al.
Publicado: (2021)

Male esthetic genital surgery: recommendations and gaps to be filled
por: Bettocchi, Carlo, et al.
Publicado: (2022)

Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy”
por: Busetto, Gian Maria, et al.
Publicado: (2023)

Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study
por: Porreca, Angelo, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer
por: Cormio, Antonella, et al.
Publicado: (2021)

Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2018)

Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence
por: Barone, Biagio, et al.
Publicado: (2023)

Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?
por: Ferro, Matteo, et al.
Publicado: (2021)

Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2022)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
por: Busetto, Gian Maria, et al.
Publicado: (2023)

Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy
por: Ferro, Matteo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hu17iq65nlqltuolu9fmo5ih47